Medical Oncology

2 researchers across 1 institution

2 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Medical oncology research investigates the causes, prevention, diagnosis, and treatment of cancer. This field encompasses a wide range of studies, including the development of new chemotherapies, immunotherapies, and targeted drug therapies. Researchers explore the molecular mechanisms underlying cancer development and progression, aiming to identify novel biomarkers for early detection and personalized treatment strategies. Studies also focus on understanding drug resistance, optimizing treatment regimens, and improving patient outcomes through clinical trials and translational research.

Given Arkansas's cancer burden, medical oncology research directly addresses significant public health challenges within the state. Efforts are made to develop and implement effective cancer care strategies that are accessible to diverse populations across Arkansas, including rural communities. Understanding the genetic and environmental factors that may contribute to cancer incidence in the state can inform targeted prevention and early detection programs. This work supports the state's healthcare sector by advancing knowledge and potentially improving patient care and reducing the economic impact of cancer.

This area of study intersects with health literacy and information accessibility, cancer genomics and diagnostics, healthcare policy, and telemedicine. Researchers collaborate across disciplines to translate laboratory findings into clinical practice and to address the complex needs of cancer patients and their families throughout Arkansas.

AI-generated overview
Filter by institution:

Top Researchers

Name Institution h-index Citations Career Stage Badges
John F. Jenkins UAMS 3 46
Tiffany L. Hall UAMS 2 17

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
4,840 works in 2026
-1.2% CAGR 2018–2026
Leadership concentration
3.4% held by global top 5 institutions
Fragmented HHI 7
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 1,776
  2. 2 Harvard University 1,344
  3. 3 Memorial Sloan Kettering Cancer Center 1,068
  4. 4 University of Pennsylvania 954
  5. 5 Johns Hopkins University 927
Browse All 2 Researchers in Directory